PRAME (425-433) (human) (trifluoroacetate salt) 5 mg | ≥95% Cayman Chemical An immunogenic T cell epitope More Information Supplier Page × PRAME (425-433) (human) (trifluoroacetate salt)
SPC25 Peptide (human, bovine) (trifluoroacetate salt) 1 mg | ≥95% Cayman Chemical A peptide fragment of SPC25 More Information Supplier Page × SPC25 Peptide (human, bovine) (trifluoroacetate salt)
PRAME (425-433) (human) (trifluoroacetate salt) 50 mg | ≥95% Cayman Chemical An immunogenic T cell epitope More Information Supplier Page × PRAME (425-433) (human) (trifluoroacetate salt)
POLA2 (22-30) (human) (trifluoroacetate salt) 50 mg | ≥95% Cayman Chemical A peptide fragment of POLA2 More Information Supplier Page × POLA2 (22-30) (human) (trifluoroacetate salt)
PRAME (425-433) (human) (trifluoroacetate salt) 10 mg | ≥95% Cayman Chemical An immunogenic T cell epitope More Information Supplier Page × PRAME (425-433) (human) (trifluoroacetate salt)
PRAME (425-433) (human) (trifluoroacetate salt) 100 mg | ≥95% Cayman Chemical An immunogenic T cell epitope More Information Supplier Page × PRAME (425-433) (human) (trifluoroacetate salt)
POLA2 (22-30) (human) (trifluoroacetate salt) 5 mg | ≥95% Cayman Chemical A peptide fragment of POLA2 More Information Supplier Page × POLA2 (22-30) (human) (trifluoroacetate salt)
POLA2 (22-30) (human) (trifluoroacetate salt) 25 mg | ≥95% Cayman Chemical A peptide fragment of POLA2 More Information Supplier Page × POLA2 (22-30) (human) (trifluoroacetate salt)
POLA2 (22-30) (human) (trifluoroacetate salt) 10 mg | ≥95% Cayman Chemical A peptide fragment of POLA2 More Information Supplier Page × POLA2 (22-30) (human) (trifluoroacetate salt)
3’-O-MOE-U-2’-phosphoramidite 25 mg | ≥95% Cayman Chemical A nucleoside building block More Information Supplier Page × 3’-O-MOE-U-2’-phosphoramidite
